Cardinal Health customers will receive special pricing for new URAC accreditations, which validate that a pharmacy meets the most rigorous standards in the industry and demonstrates the value of the clinical services it provides.
Ztalmy is the first and only FDA-approved treatment for seizures associated with CDKL5 deficiency disorder in patients aged 2 years old and older, the company said.
Tlando is an oral treatment for testosterone replacement therapy indicated for conditions associated with a deficiency or absence of endogenous testosterone or hypogonadism in adult males.
This is the first product launch under the previously announced exclusive licensing agreement between Nevakar Injectables, and Endo's subsidiary, Endo Ventures.
Through a partnership with RxRevu, FDB Vela brings real-time pharmacy benefit information to e-prescribing workflows embedded seamlessly within an EHR.
Cortrophin Gel is indicated for the treatment of certain chronic autoimmune disorders, including acute exacerbations of multiple sclerosis and rheumatoid arthritis and excess urinary protein due to nephrotic syndrome.
The acquisition marks Hikma’s expansion into Canada and includes a portfolio of 25 sterile injectable products, three in-licensed ophthalmic products and a pipeline of seven additional products.
